Landscapes / Targets
HIF-2α
5 drugs act on HIF-2α, in 27 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs5
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Hypoxia-inducible factor inhibitor |
Merck & Co. · Public MRK |
Approved | 22 Dec 2026Phase 1/2 trial completes | ||
| Next date | 22 Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Renal Cell Carcinoma, Carcinoma, Renal Cell and 38 more | ||||
| Open drug page | |||||
— |
Phase 3 | Apr 2028Phase 3 trial completes | |||
| Next date | Apr 2028 · Phase 3 trial completes | ||||
| Also tested for | Clear Cell Renal Cell Carcinoma, Solid Tumors and 3 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 10 Jul 2027Phase 1/2 trial completes | |||
| Next date | 10 Jul 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Von Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Mucositis, Nephrotoxicity and 1 more | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | ccRCC, RCC and 3 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 5 of 5 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026